MKS (NASDAQ:MKSI – Get Free Report) announced its earnings results on Wednesday. The scientific and technical instruments company reported $4.18 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.63 by $0.55, FiscalAI reports. MKS had a return on equity of 29.90% and a net margin of 12.64%. The business had revenue of $1.41 billion during the quarter, compared to analyst estimates of $1.36 billion. During the same quarter in the previous year, the business earned $1.93 earnings per share. The company’s revenue for the quarter was up 43.0% compared to the same quarter last year.
MKS Price Performance
NASDAQ MKSI traded up $15.06 on Friday, hitting $191.88. The company had a trading volume of 1,394,344 shares, compared to its average volume of 1,390,152. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.14 and a quick ratio of 0.72. The company’s fifty day moving average price is $241.71 and its 200-day moving average price is $277.11. The company has a market capitalization of $12.97 billion, a PE ratio of 22.69, a PEG ratio of 0.41 and a beta of 2.14. MKS has a 12-month low of $134.74 and a 12-month high of $447.62.
MKS Dividend Announcement
The business also recently declared a quarterly dividend, which will be paid on Monday, December 7th. Investors of record on Wednesday, November 25th will be paid a $0.25 dividend. The ex-dividend date of this dividend is Wednesday, November 25th. This represents a $1.00 dividend on an annualized basis and a yield of 0.5%. MKS’s dividend payout ratio (DPR) is currently 11.86%.
Analysts Set New Price Targets
Several research firms have recently weighed in on MKSI. Wells Fargo & Company decreased their target price on MKS from $285.00 to $195.00 and set an “equal weight” rating for the company in a research report on Friday. Deutsche Bank Aktiengesellschaft set a $360.00 target price on MKS in a research note on Friday, July 31st. Morgan Stanley dropped their target price on MKS from $345.00 to $330.00 and set an “overweight” rating on the stock in a research note on Monday, October 26th. JPMorgan Chase & Co. boosted their target price on shares of MKS from $365.00 to $380.00 and gave the stock an “overweight” rating in a research report on Friday, August 7th. Finally, Weiss Ratings downgraded MKS from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Monday, September 28th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have given a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $359.14.
Read Our Latest Stock Report on MKS
MKS announced that its Board of Directors has approved a stock repurchase program on Wednesday, November 4th that authorizes the company to repurchase $500 million in outstanding shares. This repurchase authorization authorizes the scientific and technical instruments company to reacquire up to 3.6% of its stock through open market purchases. Share repurchase programs are generally a sign that the company’s leadership believes its shares are undervalued.
Key Headlines Impacting MKS
Here are the key news stories impacting MKS this week:
- Positive Sentiment: Strong Q3 results and upbeat outlook: MKS reported adjusted EPS of $4.18, above the roughly $3.63 consensus, while revenue rose 43% year over year to $1.41 billion and topped estimates. The company forecast Q4 adjusted EPS of $4.62–$5.38, and coverage cited AI-fueled semiconductor growth as a driver. Article: MKSI Q3 Earnings Beat Estimates on Strong Semiconductor Growth
- Positive Sentiment: $500 million share-repurchase authorization: The program allows MKS to buy back up to 3.6% of its shares, potentially supporting per-share results and signaling management confidence. Article: MKS Announces Share Repurchase Program and Dividend
- Neutral Sentiment: MKS also declared a quarterly dividend of $0.25 per share, or $1.00 annualized. The modest 0.6% yield adds shareholder return but is less likely to be a major near-term catalyst. Article: MKS Announces Share Repurchase Program and Dividend
- Negative Sentiment: Analysts cut price targets: Wells Fargo lowered its target to $195 and moved to equal weight, implying limited upside at the cited share price. Needham also reduced its target, to $300, but maintained a buy rating. The cuts may weigh on sentiment despite the positive earnings report. Article: Wells Fargo Recommendations
Insider Activity
In related news, Director Elizabeth Mora sold 300 shares of the company’s stock in a transaction dated Tuesday, September 1st. The shares were sold at an average price of $250.96, for a total transaction of $75,288.00. Following the completion of the transaction, the director owned 18,845 shares in the company, valued at $4,729,341.20. This represents a 1.57% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CEO John Tseng-Chung Lee sold 10,000 shares of the business’s stock in a transaction that occurred on Friday, August 14th. The stock was sold at an average price of $302.01, for a total value of $3,020,100.00. Following the sale, the chief executive officer owned 134,776 shares of the company’s stock, valued at approximately $40,703,699.76. This trade represents a 6.91% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.57% of the stock is owned by company insiders.
MKS Company Profile
MKS Instruments, Inc (NASDAQ: MKSI) develops technologies that enable precision control and measurement in manufacturing and research environments. The company provides instruments, components, systems and process-control solutions used to measure and control pressure, flow, vacuum, gas delivery, temperature and other critical production conditions.
Its product portfolio includes vacuum solutions, pressure and flow-control instruments, gas and vapor delivery systems, plasma and reactive-gas technologies, power delivery systems, process-monitoring equipment, analytical instruments and materials-characterization tools.
Featured Stories
- Five stocks we like better than MKS
- Q3 Earnings Have Investors Wondering: Is Mercado Libre Finally a Buy?
- CVS Raised Its Outlook and Announced a Breakup—So Why Did the Stock Drop?
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
Receive News & Ratings for MKS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MKS and related companies with MarketBeat.com's FREE daily email newsletter.
